-transparent.png){kind=logo}
We measured the cerebrospinal fluid (CSF) levels of beta-endorphin in 7 Japanese patients with Joseph disease and compared them with control values. The 7 patients included 4 with type I and 3 with type II disease; their mean age was 45.7 +/- 12.09 years. Diseased controls were matched in age to the patients studied. In these patients, CSF beta-endorphin level was significantly lower than in the controls (40% of normal values). An alteration in CSF beta-endorphin level may explain some of the neurological impairment found in Joseph disease.
Related Publications
T Matsuishi, and
T Sakai, and
S Nagamitsu, and
H Komori, and
H Iwashita, and
H Kato
January 2001,
Journal of neural transmission (Vienna, Austria : 1996),
T Matsuishi, and
T Sakai, and
S Nagamitsu, and
H Komori, and
H Iwashita, and
H Kato
December 1982,
Australian paediatric journal,
T Matsuishi, and
T Sakai, and
S Nagamitsu, and
H Komori, and
H Iwashita, and
H Kato
December 1988,
The Journal of rheumatology,
T Matsuishi, and
T Sakai, and
S Nagamitsu, and
H Komori, and
H Iwashita, and
H Kato
September 1993,
Scandinavian journal of gastroenterology,
T Matsuishi, and
T Sakai, and
S Nagamitsu, and
H Komori, and
H Iwashita, and
H Kato
June 2000,
Annals of neurology,
T Matsuishi, and
T Sakai, and
S Nagamitsu, and
H Komori, and
H Iwashita, and
H Kato
January 2003,
JAMA,
T Matsuishi, and
T Sakai, and
S Nagamitsu, and
H Komori, and
H Iwashita, and
H Kato
February 1987,
Journal of the neurological sciences,
T Matsuishi, and
T Sakai, and
S Nagamitsu, and
H Komori, and
H Iwashita, and
H Kato
July 1978,
Lancet (London, England),
T Matsuishi, and
T Sakai, and
S Nagamitsu, and
H Komori, and
H Iwashita, and
H Kato
December 1999,
Journal of Alzheimer's disease : JAD,
T Matsuishi, and
T Sakai, and
S Nagamitsu, and
H Komori, and
H Iwashita, and
H Kato
January 2018,
Frontiers in neuroscience,
